Olympus introduced the FDA-cleared EZ Shot 3 Plus single use aspiration needle.
EndoChoice stock declined 6.36 percent in short interest.
The European Commission approved the Swiss-based Novartis drug Afinitor for advanced gastrointestinal and lung neuroendocrine tumor treatment.
SpectraScience completed training for the first group of physicians using the WavSTAT4 Optical Biopsy SystemR in Barcelona, Spain.
More articles on GI/endoscopy:
Olympus introduces new single use aspiration needle: 4 notes
Unsafe injection practices lead to HCV outbreak, clinic closure: 4 insights
4 key points on Mercy Health-Fairfield Hospital’s $14M plan to improve inpatient & outpatient endoscopy services
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.